IDT BIOLOGIKA GMBH
DESSAU-ROSSLAU, SACHSEN-ANHALT 06861
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $7.40M | 19 |
| 325414 | $0 | 1 |
Contract Awards
8 awards found
EOI::HHS COST EFFICIENCY INITIATIVE:: EOI TO FULLY TERMINATE THIS CONTRACT FOR CONVENIENCE, EFFECTIVE APRIL 17, 2025, PURSUANT TO 52.249-2 TERMINATION FOR CONVENIENCE OF THE GOVERNMENT (FIXED-PRICE).
MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE 1 AND 2.
HHSN272201800011I IDT BIOLOGIKA; MASTER CELL BANKS MANUFACTURING FOR NEXT GENERATION SARS-COV-2 VACCINES
HHSN272201800011I IDT BIOLOGIKA MASTER CELL BANKS MANUFACTURING FOR NEXT GENERATION SARS-COV-2 VACCINES
CONTRACT HHSN272201800011I IDT BIOLOGIKA; DEVELOPMENT AND MANUFACTURE OF TOXOID FUSION MASTER BANKS
MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE 1 AND 2.
1800011I MANUFACTURING AND CHARACTERIZATION SERVICES FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES;
CONTRACT #HHSN272201800011I; IDT BIOLOGIKA; DEVELOPMENT AND MANUFACTURE OF TOXOID FUSION MASTER BANKS; CAN 8470038; TOTAL $555,600.00
Business Details
- UEI
- E14GD5J873N9
- CAGE Code
- D3395
- Address
- AM PHARMAPARK
DESSAU-ROSSLAU, 06861 - Phone
- 2405993024
Parent Company
IDT BIOLOGIKA GMBH
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov